PREventing Second Cancers With DOSTARlimab

NCT05855811 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Cancer
Primary Cancer
Second Cancer

Interventions

DRUG: Dostarlimab

Sponsor

Centre Leon Berard

Collaborators

[object Object]